Masimo RAS-45 Full-Market Release To Boost Respiratory Care
Zacks Investment Research | Oct 01, 2017 09:00PM ET
Masimo Corporation (NASDAQ:MASI) recently announced the full-market release of RAS-45, a single use adhesive respiration sensor for rainbow acoustic monitoring (RAM) of respiration rate. The launch is expected to strengthen the company’s foothold in the growing global respiratory care market.
Notably, RAM is a flagship noninvasive technology of Masimo that continuously measures respiration rate of the prospective patients using an adhesive sensor and an acoustic transducer.
RAS-45 exclusively operates for post-surgical patients undergoing patient-controlled analgesia (self-administered pain management). Here we note that RAS-45 and RAS 125-c are two notable adhesive sensors in RAM.
As per management, the RAS-45 go-ahead highlights the exclusivity of the product, which includes smaller adhesive profile, usage of transparent adhesive and flexibility compared with the likes that are available in the market. The product is also likely to empower the company’s flagship signal extraction (SET), rainbow and the MX technologies.
Considering bountiful opportunities for Advanced Monitoring Technologies in the global market, the launch instills investors’ confidence in the stock. A research report by Markets And Markets reveals that niche market is expected to reach a worth of $15.01 billion globally by 2022, at a CAGR of 8.5%.
Additionally, Masimo’s long-term growth fundamentals are strong. The Irvine, CA-based company recorded a five-year CAGR of 8.5% for revenues and 9.1% for adjusted earnings per share. Masimo has particularly witnessed an improvement in earnings over the last three years.
Masimo develops, manufactures and markets a family of non-invasive monitoring systems. The latest development would significantly fortify the company’s position in niche markets.
Masimo carries a Zacks Rank #2 (Buy). Year to date, Masimo has outperformed the Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.